Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
The European Journal of Health Economics
Published in: The European Journal of Health Economics 7/2014

01-09-2014 | Editorial

HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain

Authors: L. Gulácsi, M. Péntek

Published in: The European Journal of Health Economics | Issue 7/2014

Login to get access

Excerpt

Most of the countries in Central and Eastern Europe (CEE) experienced a decrease of their gross domestic product (GDP) due to the financial crisis, followed by a longer than projected stagnation period suffering from the lack of economic growth. While several papers have been published on the impact of the crisis on health care systems in the past years, very few of them were focused on the health status of the population, and almost none of them provided valid data on health loss due to the crises. Numerous papers focused on Greece and on those countries that were affected most by the recession [1, 2]. However, there is limited knowledge on the impact of the economic recession on health and health care in the CEE member states of the European Union (EU). …
Literature
1.
Kousoulis, A.A., Angelopoulou, K.E., Lionis, C.: Exploring health care reform in a changing Europe: Lessons from Greece. Eur J Gen Pract 19(3), 194–199 (2013)CrossRefPubMed
2.
Vandoros, S., Hessel, P., Leone, T., Avendano, M.: Have health trends worsened in Greece as a result of the financial crisis? A quasi-experimental approach. Eur J Public Health 23(5), 727–731 (2013)CrossRefPubMed
3.
Eris M. (2012): Improving Health Outcomes and System in Hungary. OECD Economics Department Working Papers, No. 961. OECD
4.
Gaál, P., Sz, Szigeti, Panteli, D., Gaskins, M., van Ginneken, E.: Major challenges ahead for Hungarian health care; The health sector in Hungary is facing its most serious crisis since the fall of the communist regime. BMJ 343, d7657 (2011). doi:10.​1136/​bmj.​d7657 CrossRefPubMed
5.
OECD 2010, “Health care systems: Getting more value for money”, OECD Economics Department Policy Notes, No. 2
6.
Baji, P., Boncz, I., Jenei, G., Gulácsi, L.: Comparing cost-sharing practices for pharmaceuticals and health care services among four Central European countries. Society and Economy 34(2), 221–240 (2012)CrossRef
7.
Pavlova, P., Arsenijevic, J., Goot, W., van Merode, G.G.: Projection of health service consumption and patient payment revenues in CEE countries using system dynamics modeling. Society and Economy 34(2), 359–378 (2012)CrossRef
8.
Baji, P., Pavlova, M., Gulácsi, L., Groot, W.: User fees for public health care services in Hungary: Expectations, experience, and acceptability from the perspectives of different stakeholders. Health Policy 102(2–3), 255–262 (2011)CrossRefPubMed
9.
Karanikolos, M.M.P., Cylus, J., Thomson, S., Basu, S., Stuckler, D., Mackenbach, J.P., McKee, M.: Financial crisis, austerity, and health in Europe. Lancet 381, 1323–1331 (2013)CrossRefPubMed
10.
McCormick, J., Mehta, G., Olesen, H.V., Viviani, L., Macek Jr, M., Mehta, A.: European Registry Working Group Comparative demographics of the European cystic fibrosis population: a cross-sectional database analysis. Lancet 375(9719), 1007–1013 (2010)CrossRefPubMed
11.
12.
Érsek, K., Kovács, T., Wimo, A., Kárpáti, K., Brodszky, V., Péntek, M., Jönsson, L., Gustavsson, A., McDaid, D., Kenigsberg, P.A., Valtonen, H., Gulácsi, L.: Costs of dementia in Hungary. J. Nutrition Health Aging 14(8), 633–639 (2010)CrossRef
13.
Péntek, M., Horváth, C., Boncz, I., Falusi, Z., Tóth, E., Sebestyén, A., Májer, I., Brodszky, V., Gulácsi, L.: Epidemiology of osteoporosis related fractures in Hungary from the nationwide health insurance database, 1999-2003. Osteoporos. Int. 19(2), 243–249 (2008)CrossRefPubMed
14.
Sebestyén, A., Boncz, I., Sándor, J., Nyárády, J.: Effect of surgical delay on early mortality in patients with femoral neck fracture. Int. Orthop. 32(3), 375–379 (2008)PubMedCentralCrossRefPubMed
15.
Boncz, I., Sebestyén, A., Pintér, I., Betlehem, J., Kriszbacher, I., Csere, T., Mangel, L., Bódis, J.: Age group specific gap between treatment cost of and mortality due to breast and colorectal cancer. J. Clin. Oncol. 25(28), 4501–4502 (2007)CrossRefPubMed
16.
Boncz, I., Sebestyén, A., Pintér, I., Battyány, I., Ember, I.: The effect of an organized, nationwide breast cancer screening programme on non-organized mammography activities. J. Med. Screen. 15(1), 14–17 (2008)CrossRefPubMed
17.
Laki, J., Mónok, G., Pálosi, M., Gajdácsi, J.Z.: Economical aspect of biological therapy in inflammatory conditions in Hungary. Expert Opin Biol Ther. 13(3), 327–337 (2013)CrossRefPubMed
18.
Minier, T., Péntek, M., Brodszky, V., Ecseki, A., Kárpáti, K., Polgár, A., Czirják, L., Gulácsi, L.: Cost-of-illness of patients with systemic sclerosis in a tertiary care centre. Rheumatology (Oxford) 49(10), 1920–1928 (2010)CrossRef
19.
Inotai, A., Rojkovich, B., Fülöp, A., Jászay, E., Agh, T., Mészáros, A.: Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis. Rheumatol. Int. 32(4), 963–969 (2012)CrossRefPubMed
20.
Putrik, P., Ramiro, S., Kvien, T.K., Sokka, T., Uhlig, T., Boonen, A.: on behalf of Equity in Clinical Eligibility Criteria for RA treatment Working Group. Variations in criteria regulating treatment with reimbursed biologic DMARDs across European countries. Are differences related to country’s wealth? Ann. Rheum. Dis. (2013). doi:10.​1136/​annrheumdis-2013-203819
21.
Antonanzas, F., Rodriguez-Ibeas, R.: Channeling health economics research initiatives to improve decision-making process in EU. Eur. J Health Econ 14, 847–852 (2013)CrossRefPubMed
22.
Kaló, Z., Landa, K., Dolezal, T., Vokó, Z.: Transferability of National Institute for Health and Clinical Excellence recommendations for pharmaceutical therapies in oncology to Central-Eastern European countries. Eur. J. Cancer Care (2012). doi:10.​1111/​j.​1365-2354.​2012.​01351.​x
23.
Gulácsi, L., Orlewska, E., Péntek, M.: Health economics and health technology assessment in Central and Eastern Europe: a dose of reality. Eur J Health Econ 13(5), 525–531 (2012)CrossRefPubMed
24.
Ozieranski, P., McKee, M., King, L.: The politics of health technology assessment in Poland. Health Policy 108(2–3), 178–193 (2012)CrossRefPubMed
25.
Jóna G., A GYEMSZI Technológia-értékelő Főosztály tapasztalataiból. Corvinus Health Policy Series Conference 2011.10.03. Budapest
26.
Cleemput, I., Neyt, M., Thiry, N., de Laet, C., Leys, M.: Using threshold values for cost per quality-adjusted life year gained in health care decisions. Int. J. Technol. Assess. Health Care 27, 71–76 (2011)CrossRefPubMed
27.
McCabe, C., Claxton, K., Culyer, A.J.: The NICE Cost-Effectiveness threshold. What it is and What that Means, Pharmacoeconomics 26(9), 733–744 (2008)
Metadata
Title
HTA in Central and Eastern European countries; the 2001: A Space Odyssey and efficiency gain
Authors
L. Gulácsi
M. Péntek
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
The European Journal of Health Economics / Issue 7/2014
Print ISSN: 1618-7598
Electronic ISSN: 1618-7601
DOI
https://doi.org/10.1007/s10198-014-0608-2

Other articles of this Issue 7/2014

The European Journal of Health Economics 7/2014 Go to the issue

Original Paper

Lead me not into temptation: drug price regulation and dispensing physicians in Switzerland

Original Paper

Employment effects of hospital privatization in Germany

Original Paper

Public funding of pharmaceuticals in the Netherlands: investigating the effect of evidence, process and context on CVZ decision-making

Original Paper

Choice of insurer for basic health insurance restricted by supplementary insurance

Original Paper

Cost-effectiveness of lung transplantation and its evolution: the Portuguese case

Original Paper

Applying discrete choice modelling in a priority setting: an investigation of public preferences for primary care models